{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:17:10Z","timestamp":1788909430256,"version":"build-2803163510"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"National Cancer Institute","award":["ZIA BC 010449"],"award-info":[{"award-number":["ZIA BC 010449"]}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0222202","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T17:36:50Z","timestamp":1568223410000},"page":"e0222202","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6475-1722","authenticated-orcid":true,"given":"Henrique Bregolin","family":"Dias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarbas Rodrigues","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8836-9109","authenticated-orcid":true,"given":"M\u00e1rcio Vin\u00edcius Fagundes","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-6818","authenticated-orcid":true,"given":"Shioko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"issue":"6","key":"pone.0222202.ref001","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"G Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"pone.0222202.ref002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.JAA.0000544299.00459.a4","article-title":"Recommendations for evaluating and managing idiopathic pulmonary fibrosis","volume":"31","author":"DM Provencher","year":"2018","journal-title":"JAAPA"},{"issue":"4","key":"pone.0222202.ref003","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/17476348.2017.1300533","article-title":"Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers'","volume":"11","author":"IP Tomos","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"pone.0222202.ref004","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fphys.2017.00777","article-title":"The processes and mechanisms of cardiac and pulmonary fibrosis","volume":"8","author":"LA Murtha","year":"2017","journal-title":"Front Physiol"},{"issue":"3","key":"pone.0222202.ref005","doi-asserted-by":"crossref","first-page":"L562","DOI":"10.1152\/ajplung.2000.279.3.L562","article-title":"TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?","volume":"279","author":"M Selman","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7","key":"pone.0222202.ref006","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1164\/rccm.201806-1037ED","article-title":"Targeting the myofibroblast in pulmonary fibrosis","volume":"198","author":"AV Misharin","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pone.0222202.ref007","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: one function, multiple origins","volume":"170","author":"B Hinz","year":"2007","journal-title":"Am J Pathol"},{"key":"pone.0222202.ref008","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2018.06.024","article-title":"Fructose-1,6-bisphosphate preserves glucose metabolism integrity and reduces reactive oxygen species in the brain during experimental sepsis","volume":"1698","author":"AV Catarina","year":"2018","journal-title":"Brain Res"},{"issue":"3","key":"pone.0222202.ref009","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s10753-012-9429-6","article-title":"Fructose-1,6-bisphosphate protects against Zymosan-induced acute lung injury in mice","volume":"35","author":"RC Santos","year":"2012","journal-title":"Inflammation"},{"key":"pone.0222202.ref010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.biopha.2017.01.178","article-title":"Fructose-1,6-bisphosphate decreases IL-8 levels and increases the activity of pro-apoptotic proteins in HepG2 cells","volume":"89","author":"GC Krause","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"pone.0222202.ref011","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1007\/s13277-013-1597-y","article-title":"The study of inducing apoptosis effect of fructose 1,6-bisphosphate on the papillary thyroid carcinoma cell and its related mechanism","volume":"35","author":"Y Li","year":"2014","journal-title":"Tumour Biol"},{"issue":"2","key":"pone.0222202.ref012","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s13277-013-1231-z","article-title":"Antitumor effect of fructose 1,6-bisphosphate and its mechanism in hepatocellular carcinoma cells","volume":"35","author":"YX Lu","year":"2014","journal-title":"Tumour Biol"},{"issue":"39","key":"pone.0222202.ref013","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.2174\/0929867323666161014144250","article-title":"Fructose 1,6-Bisphosphate: A summary of its cytoprotective mechanism","volume":"23","author":"N Alva","year":"2016","journal-title":"Curr Med Chem"},{"issue":"1\u20133","key":"pone.0222202.ref014","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejphar.2013.09.067","article-title":"Fructose-1,6-bisphosphate induces phenotypic reversion of activated hepatic stellate cell","volume":"720","author":"FC de Mesquita","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"pone.0222202.ref015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10534-017-0025-y","article-title":"Fructose-1,6-bisphosphate reverts iron-induced phenotype of hepatic stellate cells by chelating ferrous ions","volume":"30","author":"HB Dias","year":"2017","journal-title":"Biometals"},{"issue":"5","key":"pone.0222202.ref016","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s10753-018-0842-3","article-title":"Fructose-1,6-bisphosphate prevents bleomycin-induced pulmonary fibrosis in mice and inhibits the proliferation of lung fibroblasts","volume":"41","author":"RT Jost","year":"2018","journal-title":"Inflammation"},{"issue":"81","key":"pone.0222202.ref017","first-page":"e50601","article-title":"Noninvasive intratracheal intubation to study the pathology and physiology of mouse lung","author":"Y Cai","year":"2013","journal-title":"J Vis Exp"},{"issue":"4","key":"pone.0222202.ref018","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s10753-012-9436-7","article-title":"Fructose-1,6-bisphosphate reduces the mortality in Candida albicans bloodstream infection and prevents the septic-induced platelet decrease","volume":"35","author":"RC Santos","year":"2012","journal-title":"Inflammation"},{"issue":"4","key":"pone.0222202.ref019","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2144\/000112729","article-title":"Standardized quantification of pulmonary fibrosis in histological samples","volume":"44","author":"RH Hubner","year":"2008","journal-title":"Biotechniques"},{"key":"pone.0222202.ref020","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.biochem.77.032207.120833","article-title":"Collagen structure and stability","volume":"78","author":"MD Shoulders","year":"2009","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"pone.0222202.ref021","doi-asserted-by":"crossref","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","article-title":"Murine models of pulmonary fibrosis","volume":"294","author":"BB Moore","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"pone.0222202.ref022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/01902149209020649","article-title":"Lung cytokine production in bleomycin-induced pulmonary fibrosis","volume":"18","author":"SH Phan","year":"1992","journal-title":"Exp Lung Res"},{"issue":"7","key":"pone.0222202.ref023","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/gb-2013-14-7-r82","article-title":"A comparative phenotypic and genomic analysis of C57BL\/6J and C57BL\/6N mouse strains","volume":"14","author":"MM Simon","year":"2013","journal-title":"Genome Biol"},{"issue":"6","key":"pone.0222202.ref024","doi-asserted-by":"crossref","first-page":"L928","DOI":"10.1152\/ajplung.00012.2009","article-title":"Ekekezie, II. Higher TRIP-1 level explains diminished collagen contraction ability of fetal versus adult fibroblasts","volume":"296","author":"A Navarro","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7","key":"pone.0222202.ref025","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacbts.2016.07.007","article-title":"A transcriptomic and epigenomic comparison of fetal and adult human cardiac fibroblasts reveals novel key transcription factors in adult cardiac fibroblasts","volume":"1","author":"MKB Jonsson","year":"2016","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"pone.0222202.ref026","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/bbrc.1997.7136","article-title":"Autocrine growth regulation in fetal and adult human fibroblasts","volume":"237","author":"H Pratsinis","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"pone.0222202.ref027","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/0016-5085(95)90141-8","article-title":"Beneficial effect of fructose-1,6-bisphosphate on mitochondrial function during ischemia-reperfusion of rat liver","volume":"108","author":"W Sano","year":"1995","journal-title":"Gastroenterology"},{"issue":"6","key":"pone.0222202.ref028","first-page":"H2325","article-title":"Metabolism of exogenously applied fructose 1,6-bisphosphate in hypoxic vascular smooth muscle","volume":"267","author":"CD Hardin","year":"1994","journal-title":"Am J Physiol"},{"issue":"9","key":"pone.0222202.ref029","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11745-002-0975-2","article-title":"Destabilizing effects of fructose-1,6-bisphosphate on membrane bilayers","volume":"37","author":"WD Ehringer","year":"2002","journal-title":"Lipids"},{"issue":"6","key":"pone.0222202.ref030","doi-asserted-by":"crossref","first-page":"H2654","DOI":"10.1152\/ajpheart.2001.281.6.H2654","article-title":"Myocardial metabolism of exogenous FDP is consistent with transport by a dicarboxylate transporter","volume":"281","author":"CD Hardin","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"pone.0222202.ref031","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00007890-200209270-00008","article-title":"Storage solution containing fructose-1,6-bisphosphate inhibits the excess activation of Kupffer cells in cold liver preservation","volume":"74","author":"F Hirokawa","year":"2002","journal-title":"Transplantation"},{"issue":"5","key":"pone.0222202.ref032","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.transproceed.2004.05.040","article-title":"Protective effect of fructose-1,6-bisphosphate in the cold storage solution for liver preservation in rat hepatic transplantation","volume":"36","author":"RN Moresco","year":"2004","journal-title":"Transplant Proc"},{"issue":"2","key":"pone.0222202.ref033","first-page":"205","article-title":"Protection from ischemic renal injury by fructose-1,6-diphosphate infusion in the rat","volume":"16","author":"R Didlake","year":"1985","journal-title":"Circ Shock"},{"issue":"6","key":"pone.0222202.ref034","doi-asserted-by":"crossref","first-page":"E828","DOI":"10.1532\/HSF98.20061079","article-title":"Fructose-1,6-bisphosphate supports cerebral energy metabolism in pigs after ischemic brain injury caused by experimental particle embolization","volume":"9","author":"T Kaakinen","year":"2006","journal-title":"Heart Surg Forum"},{"issue":"3","key":"pone.0222202.ref035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.phrs.2008.01.008","article-title":"Pharmacokinetics of fructose-1,6-diphosphate after intraperitoneal and oral administration to adult rats","volume":"57","author":"K Xu","year":"2008","journal-title":"Pharmacol Res"},{"issue":"2","key":"pone.0222202.ref036","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1515\/acph-2015-0020","article-title":"Rational application of fructose-1,6-diphosphate: From the perspective of pharmacokinetics","volume":"65","author":"TT Li","year":"2015","journal-title":"Acta Pharm"},{"issue":"7","key":"pone.0222202.ref037","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/00003246-200207000-00034","article-title":"Fructose-1,6-diphosphate attenuates acute lung injury induced by ischemia-reperfusion in rats","volume":"30","author":"SJ Chu","year":"2002","journal-title":"Crit Care Med"},{"issue":"5","key":"pone.0222202.ref038","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/thx.54.5.390","article-title":"Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis","volume":"54","author":"S Nava","year":"1999","journal-title":"Thorax"},{"issue":"6","key":"pone.0222202.ref039","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1159\/000368163","article-title":"The role of extracellular matrix quality in pulmonary fibrosis","volume":"88","author":"JH Kristensen","year":"2014","journal-title":"Respiration"},{"key":"pone.0222202.ref040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.matbio.2015.02.002","article-title":"Matrix metalloproteinases in destructive lung disease","volume":"44\u201346","author":"AM Houghton","year":"2015","journal-title":"Matrix Biol"},{"issue":"1","key":"pone.0222202.ref041","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1165\/rcmb.2008-0487OC","article-title":"Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases","volume":"42","author":"JA Vanoirbeek","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"pone.0222202.ref042","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm.2208","article-title":"Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment","volume":"16","author":"V Barry-Hamilton","year":"2010","journal-title":"Nat Med"},{"issue":"4","key":"pone.0222202.ref043","first-page":"317","article-title":"Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis","volume":"50","author":"T Oggionni","year":"2006","journal-title":"Eur J Histochem"},{"issue":"2","key":"pone.0222202.ref044","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/ars.2007.1897","article-title":"The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis","volume":"10","author":"BD Bringardner","year":"2008","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"pone.0222202.ref045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","author":"UM Domanska","year":"2013","journal-title":"Eur J Cancer"},{"issue":"8","key":"pone.0222202.ref046","doi-asserted-by":"crossref","first-page":"e104746","DOI":"10.1371\/journal.pone.0104746","article-title":"CXCL12 induces connective tissue growth factor expression in human lung fibroblasts through the Rac1\/ERK, JNK, and AP-1 pathways","volume":"9","author":"CH Lin","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"pone.0222202.ref047","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s42255-018-0008-5","article-title":"Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis","volume":"1","author":"X Zhao","year":"2019","journal-title":"Nature Metabolism"},{"issue":"12","key":"pone.0222202.ref048","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/exd.12279","article-title":"Fructose 1, 6-diphosphate regulates desmosomal proteins and collagen fibres in human skin equivalents","volume":"22","author":"H Choi","year":"2013","journal-title":"Exp Dermatol"},{"issue":"12","key":"pone.0222202.ref049","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1164\/rccm.201504-0780OC","article-title":"Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis","volume":"192","author":"N Xie","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0222202.ref050","doi-asserted-by":"crossref","first-page":"e000183","DOI":"10.1136\/bmjresp-2017-000183","article-title":"Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study","volume":"4","author":"YD Zhao","year":"2017","journal-title":"BMJ Open Respir Res"},{"issue":"5930","key":"pone.0222202.ref051","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"MG Vander Heiden","year":"2009","journal-title":"Science"},{"key":"pone.0222202.ref052","doi-asserted-by":"crossref","first-page":"15171","DOI":"10.1038\/srep15171","article-title":"Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway","volume":"5","author":"FP Veras","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0222202.ref053","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00000542-199802000-00025","article-title":"Fructose-1,6-bisphosphate preserves adenosine triphosphate but not intracellular pH during hypoxia in respiring neonatal rat brain slices","volume":"88","author":"MT Espanol","year":"1998","journal-title":"Anesthesiology"},{"key":"pone.0222202.ref054","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1042\/bj0950868","article-title":"Properties of phosphofructokinase from rat liver and their relation to the control of glycolysis and gluconeogenesis","volume":"95","author":"AH Underwood","year":"1965","journal-title":"Biochem J"},{"issue":"3","key":"pone.0222202.ref055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1513\/pats.200708-146DR","article-title":"Biology of fibroblasts and myofibroblasts","volume":"5","author":"SH Phan","year":"2008","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"pone.0222202.ref056","doi-asserted-by":"crossref","first-page":"L162","DOI":"10.1152\/ajplung.00037.2018","article-title":"Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis","volume":"315","author":"DW Waters","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"pone.0222202.ref057","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.3892\/or.2016.5111","article-title":"Rapamycin and fructose-1,6-bisphosphate reduce the HEPG2 cell proliferation via increase of free radicals and apoptosis","volume":"36","author":"EF da Silva","year":"2016","journal-title":"Oncol Rep"},{"issue":"4","key":"pone.0222202.ref058","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"V Krizhanovsky","year":"2008","journal-title":"Cell"},{"issue":"1","key":"pone.0222202.ref059","doi-asserted-by":"crossref","first-page":"114","DOI":"10.18632\/aging.101127","article-title":"Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis","volume":"9","author":"M Mellone","year":"2016","journal-title":"Aging (Albany NY)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0222202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T08:06:58Z","timestamp":1664352418000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0222202"}},"subtitle":[],"editor":[{"given":"Oliver","family":"Eickelberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0222202","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]}}}